scientific commentaries
An enzyme in disguise
aBiochemistry and Structural Biology, Lund University, Lund, Sweden
*Correspondence e-mail: anders.liljas@biochemistry.lu.se
Keywords: catalytic metal ions; copper–carbonic anhydrase II; carbonic anhydrases; nitrite reductases.
Carbonic anhydrase (CA) is a very well known enzyme that was discovered more than 80 years ago (Meldrum & Roughton, 1933). It is responsible for catalyzing the conversion of carbon dioxide to bicarbonate in all cells and the opposite conversion in the lungs. Several forms of the enzyme have been identified as well as numerous isoenzymes of the human α form (Lomelino et al., 2018). The different forms are found in different species and isoenzymes are located in various human cell types. An exciting discovery is that isoenzymes IX and XII are associated with cancer cells and are probably important for cancer growth (Pastorekova et al., 2007, 2008).
All carbonic anhydrases are metal enzymes, with zinc as the prime metal. In the first structure of carbonic anhydrase (αCAII), a zinc ion was seen bound to three histidine residues at the core of the active site (Liljas et al., 1972). In studies of nitride reductase it was observed that the metal, in this case copper, was bound at two sites, type 1 and type 2. The type 2 copper is bound with the same configuration as in CA, by three histidines (Strange et al., 1995). Based on the similarity in substrate structure, Aamand et al. (2009) investigated whether CA could reduce nitrite. They found this to be the case but an explanation could not be envisioned. Andring et al. (2018) also made a thorough study but could not repeat the results of Aamand et al. (2009).
Among the extensive crystallographic investigations of CA some have involved changing the metal. Håkansson et al. (1994) observed that when the zinc ion was exchanged for copper, one additional copper site could be observed. This was in the floppy N-terminal region containing two His residues. In addition, they observed a presumed diatomic molecule bound to the copper at the classical active site. Similarly, Ferraroni et al. (2018) observed two copper atoms bound as well as the diatomic molecule at the active site. Neither of these studies made any connection to nitrite reductase.
In the current issue of IUCrJ, Andring et al. (2020) have been able to unravel the mystery. Carbonic anhydrase (αCAII) binds zinc as well as copper physiologically. The zinc-bound enzyme catalyzes the reversible conversion between carbon dioxide and bicarbonate. The same enzyme with two bound copper ions functions as a nitrite reductase. The classical active site for copper is site 2 where the reduction takes place. The diatomic `molecule' seen in several studies is here interpreted as NO2− that has somehow been generated. At the other site (1) at the N-terminus copper binds in a manner that imitates binding to a porphyrin ring. The role of this site is to reduce the copper in the active site. The flexible His64 between the two sites, as well as a number of bound water molecules, are probably engaged in electron transport between the two sites (Fig. 1).
This discovery, which has eluded the field for so long, is both remarkable and unusual. The long-standing assumption of a relatively simple role for the enzyme carbonic anhydrase has missed its second role as a more complex nitrite reductase. This discovery should lead to further experiments and research to better elucidate the role of this enzyme and decipher how these new insights could be applied in medical treatments.
References
Aamand, R., Dalsgaard, T., Jensen, F. B., Simonsen, U., Roepstorff, A. & Fago, A. (2009). Am. J. Physiol. Heart Circ. Physiol. 297, H2068–H2074. CrossRef PubMed CAS Google Scholar
Andring, J. T., Kim, C. U. & McKenna, R. (2020). IUCrJ, 7, 287–293. CrossRef IUCr Journals Google Scholar
Andring, J. T., Lomelino, C. L., Tu, C., Silverman, D. N., McKenna, R. & Swenson, E. R. (2018). Free Radic. Biol. Med. 117, 1–5. CrossRef CAS PubMed Google Scholar
Ferraroni, M., Gaspari, R., Scozzafava, A., Cavalli, A. & Supuran, C. T. (2018). J. Enz. Inhib. Med. Chem. 33, 999–1005. CrossRef CAS Google Scholar
Håkansson, K., Wehnert, A. & Liljas, A. (1994). Acta Cryst. D50, 93–100. CrossRef IUCr Journals Google Scholar
Liljas, A., Kannan, K. K., Bergstén, P. C., Waara, I., Fridborg, K., Strandberg, B., Carlbom, U., Järup, L., Lövgren, S. & Petef, M. (1972). Nature New Biol. 235, 131–137. CrossRef CAS PubMed Google Scholar
Lomelino, C. L., Andring, J. T. & McKenna, R. (2018). Int. J. Med. Chem. 2018, 1–21. Google Scholar
Meldrum, N. U. & Roughton, F. J. W. (1933). J. Physiol. 80, 113–142. CrossRef PubMed CAS Google Scholar
Pastorekova, S., Kopacek, J. & Pastorek, J. (2007). Curr. Top. Med. Chem. 7, 865–878. CrossRef PubMed CAS Google Scholar
Pastorekova, S., Zatovicova, M. & Pastorek, J. (2008). Curr. Pharm. Des. 14, 685–698. PubMed CAS Google Scholar
Strange, R. W., Dodd, F. E., Abraham, Z. H., Grossmann, J. G., Brüser, T., Eady, R. R., Smith, B. E. & Hasnain, S. S. (1995). Nat. Struct. Mol. Biol. 2, 287–292. CrossRef CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.